ALPS ETFs in Biotech and Commodities Lead 2025 Gains

Core Insights - Biotech and natural resources funds were the top performers in the ALPS ETFs lineup for 2025, each achieving returns exceeding 45% [1] - The ALPS Medical Breakthroughs ETF (SBIO) specifically recorded significant gains, contributing to the overall strong performance of biotech funds [1] Performance Summary - Biotech funds delivered returns above 45%, indicating robust growth in the sector [1] - Natural resources funds also matched this performance, highlighting a strong interest and investment in these areas [1]